BioSpace News Archive

Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA”), a leader in PCR-based DNA technologies, today announced that it has been invited to present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest, on June 20-22, 2023.

Nephron Pharmaceuticals Corporation announced Christopher Fortier, PharmD, FASHP, CPEL, will join as President of its 503B Outsourcing Facility.

Somatus, the nation’s leading and largest value-based kidney care company, and Kidney Care Center announced a significant expansion to their existing collaborative efforts.

In patients with neurological diseases like Alzheimer’s disease and multiple sclerosis, immune cells in the brain known as microglia that normally fulfill beneficial functions become harmful to neurons, leading to cognitive dysfunction and motor impairment.

Zhaoke Ophthalmology Limited is pleased to announce that the Company has entered into an exclusive license, supply and distribution agreement with Eyedetec Medical, Inc., a leading US-based company specializing in medical devices for the treatment of dry eye disease and meibomian gland dysfunction.

A leader in innovative medical devices, is proud to announce clearance from the U.S. Food and Drug Administration for their proprietary TiLink-L Sacroiliac Joint Fusion System.

Burning Rock Biotech Limited is pleased to announce that our flagship comprehensive genomic profiling product, OncoScreenTM Plus, was featured in a phase 3 multi-regional clinical trial, along with FoundationOneCDx, in support of advancement in breast cancer treatment.

Akoya Biosciences, Inc. announced the pricing of its public offering of 8,700,000 shares of common stock at a public offering price of $5.00 per share for gross proceeds of approximately $43.5 million, without giving effect to the underwriting discount and commission as well as estimated expenses payable by Akoya.

ObsEva SA, a biopharmaceutical company developing novel therapies for women’s health, published the invitation to its 2023 Annual General Meeting of Shareholders to be held on June 29, 2023, at 10:30 CEST at the company’s offices in Geneva, Chemin des Aulx 12, 3rd floor, 1228 Plan-les-Ouates, Switzerland.

Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit